Emily Brabbit News Today

ReNAgade Therapeutics a company unlocking the limitless potential for RNA medicines today announced its ongoing commitment to unlock the potential of glycobiology through support for ongoing research at GanNA Bio and an integration of the key founders of GanNA Bio into the ReNAgade ecosystem.

ReNAgade Therapeutics a company unlocking the limitless potential for RNA medicines today announced an oral and poster presentation highlighting preclinical data supporting its comprehensive RNA technology platform at the American Society of Gene Cell Therapy ASGCT 27th Annual Meeting being held May 711 2024 in Baltimore Maryland.

ReNAgade Therapeutics a company unlocking the limitless potential for RNA medicines today announced that Amit D. Munshi Chief Executive Officer will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday January 9 2024 at 830 a.m. PT in San Francisco CA.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced the appointment of Paul Perreault to its Board of Directors, effective December 5, 2023. Mr. Perreault most recently served as Chief Executive Officer of CSL and brings over 40 yea...

ReNAgade Therapeutics a company unlocking the limitless potential for RNA medicines today announced it will present preclinical data demonstrating novel and proprietary lipid nanoparticle LNPbased delivery of mRNA to extrahepatic tissue in a plenary session at the 11th International mRNA Health Conference being held October 31 to November 2 2023 in Berlin Germany.

ReNAgade Therapeutics a company unlocking the limitless potential for RNA medicines today announced the appointment of Laurie Stelzer as Chief Financial Officer. Ms. Stelzer most recently served as Chief Financial Officer of Mirati Therapeutics and brings over 25 years of experience to further strengthen ReNAgades leadership team.